BACKGROUND: The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N = 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory variables and the nominal 3-level decision-making variable: patient-only, patient-physician shared, and physician-only. RESULTS: Approximately 41% of patients reported patient-only decision-making, 45% reported shared decision-making, and 13% reported physician-only decision-making. The odds of patient-only over physician-only decision-making were greater for younger men (vs those aged ≥ 65 years) (odds ratio [OR], 1.68; 95% confidence interval [95% CI], 1.03-2.74), and were less for men with high (vs low) cancer aggressiveness (OR,0.29; 95% CI, 0.15-0.55). The odds of shared over physician-only decision-making were less for men with high (vs low) cancer aggressiveness (OR, 0.40; 95% CI, 0.22-0.73). Greater odds of patient-only and shared decision-making also were found to be associated with greater concerns about the physical impact of treatment and having enough time for decision-making and lower scores of receiving advice from others. CONCLUSIONS: The findings of the current study indicate that, to facilitate a more patient-oriented decision-making process regarding treatment in those with clinically localized prostate cancer, clinicians need to tailor their interventions according to patient age and cancer aggressiveness, help reduce patient concerns and misconceptions regarding the physical impact of treatments, allow sufficient time for patients to consider treatment options, and assist patients in balancing advice and information received from different sources.
BACKGROUND: The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N = 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory variables and the nominal 3-level decision-making variable: patient-only, patient-physician shared, and physician-only. RESULTS: Approximately 41% of patients reported patient-only decision-making, 45% reported shared decision-making, and 13% reported physician-only decision-making. The odds of patient-only over physician-only decision-making were greater for younger men (vs those aged ≥ 65 years) (odds ratio [OR], 1.68; 95% confidence interval [95% CI], 1.03-2.74), and were less for men with high (vs low) cancer aggressiveness (OR,0.29; 95% CI, 0.15-0.55). The odds of shared over physician-only decision-making were less for men with high (vs low) cancer aggressiveness (OR, 0.40; 95% CI, 0.22-0.73). Greater odds of patient-only and shared decision-making also were found to be associated with greater concerns about the physical impact of treatment and having enough time for decision-making and lower scores of receiving advice from others. CONCLUSIONS: The findings of the current study indicate that, to facilitate a more patient-oriented decision-making process regarding treatment in those with clinically localized prostate cancer, clinicians need to tailor their interventions according to patientage and cancer aggressiveness, help reduce patient concerns and misconceptions regarding the physical impact of treatments, allow sufficient time for patients to consider treatment options, and assist patients in balancing advice and information received from different sources.
Authors: Nancy L Keating; Mary Beth Landrum; Neeraj K Arora; Jennifer L Malin; Patricia A Ganz; Michelle van Ryn; Jane C Weeks Journal: J Clin Oncol Date: 2010-08-16 Impact factor: 44.544
Authors: Donna L Berry; William J Ellis; Nancy Fugate Woods; Christina Schwien; Kristin H Mullen; Claire Yang Journal: Urol Oncol Date: 2003 Mar-Apr Impact factor: 3.498
Authors: Stephanie L McFall; Patricia D Mullen; Theresa L Byrd; Scott B Cantor; Yen-Chi Le; Isabel Torres-Vigil; Curtis Pettaway; Robert J Volk Journal: Health Expect Date: 2014-02-09 Impact factor: 3.377
Authors: Emily C Serrell; Moritz Hansen; Greg Mills; Andrew Perry; Tracy Robbins; Melanie Feinberg; Scot C Remick; Lisa Beaule; Matt Hayn; Tom Kinkead; Paul K J Han; Jesse D Sammon Journal: World J Urol Date: 2018-08-27 Impact factor: 4.226
Authors: Michael A Diefenbach; Catherine Benedict; Suzanne M Miller; Annette L Stanton; Mary E Ropka; Kuang-Yi Wen; Linda G Fleisher; Nihal E Mohamed; Simon J Hall Journal: Transl Behav Med Date: 2018-11-21 Impact factor: 3.046
Authors: Yolanda M Hyde; Barbara Germino; Merle Mishel; Richard L Street; Lenora Campbell; Dale Brashers; Thomas P Mccoy Journal: J Best Pract Health Prof Divers Date: 2013
Authors: Sascha M Keij; Joyce E de Boer; Anne M Stiggelbout; Wändi Bruine de Bruin; Ellen Peters; Saïda Moaddine; Marleen Kunneman; Arwen H Pieterse Journal: BMJ Open Date: 2022-05-24 Impact factor: 3.006
Authors: Matthew J Resnick; Tatsuki Koyama; Kang-Hsien Fan; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Arnold L Potosky; Janet L Stanford; Antoinette M Stroup; R Lawrence Van Horn; David F Penson Journal: N Engl J Med Date: 2013-01-31 Impact factor: 91.245
Authors: Karen A Scherr; Angela Fagerlin; Timothy Hofer; Laura D Scherer; Margaret Holmes-Rovner; Lillie D Williamson; Valerie C Kahn; Jeffrey S Montgomery; Kirsten L Greene; Biqi Zhang; Peter A Ubel Journal: Med Decis Making Date: 2016-08-10 Impact factor: 2.583
Authors: Stephen G Henry; Danielle Czarnecki; Valerie C Kahn; Wen-Ying Sylvia Chou; Angela Fagerlin; Peter A Ubel; David R Rovner; Stewart C Alexander; Sara J Knight; Margaret Holmes-Rovner Journal: Health Expect Date: 2013-12-22 Impact factor: 3.377
Authors: Maarten Cuypers; Romy E D Lamers; Paul J M Kil; Lonneke V van de Poll-Franse; Marieke de Vries Journal: Trials Date: 2015-05-27 Impact factor: 2.279